TOPICS

Tag: Immunotherapy

A Comparative Study of Intralesional Vitamin D3, Measles Mumps Rubella Vaccine, and Tuberculin Purified Protein Derivative in the Treatment of Recalcitrant Warts: An Approach to Solve a Therapeutic Conundrum

J Clin Aesthet Dermatol. 2021;14(11):26–34. by Srishti Jain, MD, DNB, and Yogesh S. Marfatia, MD Dr. Jain is with North Delhi Municipal Corporation Medical College & Hindu Rao Hospital in Delhi, India. Dr. Marfatia is with the SBKS Medical Institute and Research Center in Vadodara, India. FUNDING: No funding was provided for this article. DISCLOSURES:

CONTINUE READING »

Intralesional Immunotherapy with Measles Mumps Rubella Vaccine for the Treatment of Anogenital Warts: An Open-label Study

by Shilpi Sharma, MD, and Saurabh Agarwal, MD Dr. Sharma is Assistant Professor in the Department of Dermatology, Venereology, and Leprology at the Government Medical College Haldwani in Uttarakhand, India. Dr. Agarwal is Professor and Unit Head of the Department of Dermatology, Venereology, and Leprology at the Government Medical College Haldwani in Uttarakhand, India. J

CONTINUE READING »

Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial

by Guneet Awal, MBBS, MD, and Simplepreet Kaur, MBBS, MD Drs. Awal and Kaur are with the Department of Dermatology, Venereology, and Leprosy and Sri Guru Ram Das Institute of Medical Sciences and Research in Amritsar, India.  J Clin Aesthet Dermatol. 2018;11(5):15–20 Funding: No funding was provided for this article. Disclosures: The authors have no

CONTINUE READING »